Mettl3 may play a role through several key pathways, including the MAPK cascade, ubiquitin-dependent processes, RNA splicing, and regulation of cellular processes.[81] Resistance to gemcitabine, a first-line drug for pancreatic cancer, is a significant contributor to high mortality rates. Here, METTL3 is linked to familial pancreatic carcinoma.